Logo image of FICV

FRONTIER INVESTMENT CORP -A (FICV) Stock Fundamental Analysis

NASDAQ:FICV - Nasdaq - KYG368161090 - Common Stock - Currency: USD

10.71  0 (0%)

After market: 10.73 +0.02 (+0.19%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to FICV. FICV was compared to 0 industry peers in the Unkown industry. The financial health of FICV is average, but there are quite some concerns on its profitability. FICV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

FICV had positive earnings in the past year.
In the past year FICV has reported a negative cash flow from operations.
FICV Yearly Net Income VS EBIT VS OCF VS FCFFICV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 2M -2M 4M 6M

1.2 Ratios

Industry RankSector Rank
ROA 1.77%
ROE 23.9%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FICV Yearly ROA, ROE, ROICFICV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 1 -1 2 3

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for FICV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FICV Yearly Profit, Operating, Gross MarginsFICV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for FICV remains at a similar level compared to 1 year ago.
FICV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FICV Yearly Shares OutstandingFICV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 5M 10M 15M 20M
FICV Yearly Total Debt VS Total AssetsFICV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -0.90, we must say that FICV is in the distress zone and has some risk of bankruptcy.
There is no outstanding debt for FICV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.9
ROIC/WACCN/A
WACCN/A
FICV Yearly LT Debt VS Equity VS FCFFICV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 0.00 indicates that FICV may have some problems paying its short term obligations.
FICV has a Quick Ratio of 0.00. This is a bad value and indicates that FICV is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
FICV Yearly Current Assets VS Current LiabilitesFICV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 500K 1M 1.5M 2M 2.5M

More info and screens

0

3. Growth

3.1 Past

FICV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -58.82%.
EPS 1Y (TTM)-58.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 76.50, which means the current valuation is very expensive for FICV.
FICV is valuated expensively when we compare the Price/Earnings ratio to 24.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 76.5
Fwd PE N/A
FICV Price Earnings VS Forward Price EarningsFICV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FICV Per share dataFICV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FICV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FRONTIER INVESTMENT CORP -A

NASDAQ:FICV (2/22/2024, 8:00:00 PM)

After market: 10.73 +0.02 (+0.19%)

10.71

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-22 2022-11-22/bmo
Earnings (Next)N/A N/A
Inst Owners0.3%
Inst Owner Change0%
Ins Owners64.68%
Ins Owner Change0%
Market Cap82.79M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 76.5
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.38
P/tB 5.38
EV/EBITDA N/A
EPS(TTM)0.14
EY1.31%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS1.99
TBVpS1.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.77%
ROE 23.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z -0.9
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y60%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.42%
OCF growth 3YN/A
OCF growth 5YN/A